Wong Jakk, Piceno Yvette M, DeSantis Todd Z, Pahl Madeleine, Andersen Gary L, Vaziri Nosratola D
Center for Environmental Biotechnology, Lawrence Berkeley National Laboratory, Berkeley, California.
Second Genome, San Bruno, California.
Am J Nephrol. 2014;39(3):230-237. doi: 10.1159/000360010. Epub 2014 Mar 8.
Intestinal microbiome constitutes a symbiotic ecosystem that is essential for health, and changes in its composition/function cause various illnesses. Biochemical milieu shapes the structure and function of the microbiome. Recently, we found marked differences in the abundance of numerous bacterial taxa between ESRD and healthy individuals. Influx of urea and uric acid and dietary restriction of fruits and vegetables to prevent hyperkalemia alter ESRD patients' intestinal milieu. We hypothesized that relative abundances of bacteria possessing urease, uricase, and p-cresol- and indole-producing enzymes is increased, while abundance of bacteria containing enzymes converting dietary fiber to short-chain fatty acids (SCFA) is reduced in ESRD.
Reference sets of bacteria containing genes of interest were compiled to family, and sets of intestinal bacterial families showing differential abundances between 12 healthy and 24 ESRD individuals enrolled in our original study were compiled. Overlap between sets was assessed using hypergeometric distribution tests.
Among 19 microbial families that were dominant in ESRD patients, 12 possessed urease, 5 possessed uricase, and 4 possessed indole and p-cresol-forming enzymes. Among 4 microbial families that were diminished in ESRD patients, 2 possessed butyrate-forming enzymes. Probabilities of these overlapping distributions were <0.05.
ESRD patients exhibited significant expansion of bacterial families possessing urease, uricase, and indole and p-cresol forming enzymes, and contraction of families possessing butyrate-forming enzymes. Given the deleterious effects of indoxyl sulfate, p-cresol sulfate, and urea-derived ammonia, and beneficial actions of SCFA, these changes in intestinal microbial metabolism contribute to uremic toxicity and inflammation.
肠道微生物群构成了一个对健康至关重要的共生生态系统,其组成/功能的变化会引发各种疾病。生化环境塑造了微生物群的结构和功能。最近,我们发现终末期肾病(ESRD)患者与健康个体之间众多细菌类群的丰度存在显著差异。尿素和尿酸的流入以及为预防高钾血症而对水果和蔬菜的饮食限制改变了ESRD患者的肠道环境。我们推测,在ESRD患者中,拥有脲酶、尿酸酶、对甲酚和吲哚生成酶的细菌相对丰度增加,而含有将膳食纤维转化为短链脂肪酸(SCFA)的酶的细菌丰度降低。
将含有感兴趣基因的细菌参考集整理到科水平,并整理出我们原始研究中纳入的12名健康个体和24名ESRD个体之间显示出差异丰度的肠道细菌科集。使用超几何分布检验评估集合之间的重叠情况。
在ESRD患者中占主导地位的19个微生物科中,12个拥有脲酶,5个拥有尿酸酶,4个拥有吲哚和对甲酚形成酶。在ESRD患者中减少的4个微生物科中,2个拥有丁酸形成酶。这些重叠分布的概率<0.05。
ESRD患者表现出拥有脲酶、尿酸酶、吲哚和对甲酚形成酶的细菌科显著扩张,而拥有丁酸形成酶的细菌科收缩。鉴于硫酸吲哚酚、硫酸对甲酚和尿素衍生氨的有害作用以及SCFA的有益作用,肠道微生物代谢的这些变化导致了尿毒症毒性和炎症。